v3.26.1
Business Segment Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Jul. 31, 2026
Jul. 31, 2025
Oct. 31, 2025
Segment Reporting [Line Items]          
Net sales $ 1,066.2 $ 1,060.3 $ 3,171.8 $ 3,027.3  
Cost of sales 354.3 368.3 1,029.3 996.0  
Selling, general and administrative expense 401.3 421.7 1,467.7 1,208.6  
Research and development expense 41.6 44.6 128.4 130.8  
Amortization of intangibles 47.0 50.0 142.6 149.4  
Operating income 222.0 175.7 403.8 542.5  
Interest expense 21.5 25.4 64.8 75.6  
Other (income) expense, net (1.3) (1.6) (6.6) 17.2  
Income before income taxes 201.8 151.9 345.6 449.7  
Depreciation expense 47.6 45.7 143.0 130.1  
Capital expenditures 68.7 96.9 257.3 264.4  
Total assets 12,673.4   12,673.4   $ 12,394.8
Operating Segments | CooperVision          
Segment Reporting [Line Items]          
Net sales 717.0 718.4 2,135.6 2,034.1  
Cost of sales 240.4 238.3 690.6 658.9  
Selling, general and administrative expense 244.6 248.1 734.4 714.9  
Research and development expense 22.3 24.3 66.8 72.4  
Amortization of intangibles 4.2 5.1 12.5 15.0  
Operating income 205.5 202.6 631.3 572.9  
Depreciation expense 40.9 39.0 123.3 111.4  
Capital expenditures 60.4 86.4 231.2 231.4  
Total assets 7,915.1   7,915.1   7,604.4
Operating Segments | CooperSurgical          
Segment Reporting [Line Items]          
Net sales 349.2 341.9 1,036.2 993.2  
Cost of sales 113.9 130.0 338.7 337.1  
Selling, general and administrative expense 132.1 150.9 662.9 423.6  
Research and development expense 19.3 20.3 61.6 58.4  
Amortization of intangibles 42.8 44.9 130.1 134.4  
Operating income 41.1 (4.2) (157.1) 39.7  
Depreciation expense 6.7 6.7 19.7 18.7  
Capital expenditures 8.3 10.5 26.1 33.0  
Total assets 4,542.7   4,542.7   4,619.3
Corporate          
Segment Reporting [Line Items]          
Net sales 0.0 0.0 0.0 0.0  
Cost of sales 0.0 0.0 0.0 0.0  
Selling, general and administrative expense 24.6 22.7 70.4 70.1  
Research and development expense 0.0 0.0 0.0 0.0  
Amortization of intangibles 0.0 0.0 0.0 0.0  
Operating income (24.6) (22.7) (70.4) (70.1)  
Depreciation expense 0.0 0.0 0.0 0.0  
Capital expenditures 0.0 $ 0.0 0.0 $ 0.0  
Total assets $ 215.6   $ 215.6   $ 171.1